-
PurposeLentiviral vector expressing human codon-optimized S. pyogenes FLAG-tagged Cas9 and blasticidin resistance from EFS promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 73310 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonelenti CRISPR pXPR_001
-
Backbone manufacturerFeng Zhang
- Backbone size w/o insert (bp) 6990
- Total vector size (bp) 11214
-
Modifications to backboneCas9-2A‐Blasticidin vector was modified from lentiCRISPR pXPR_001 (Addgene 49535) by removing the gRNA expressing sequence through NdeI, EcoRI digest and blunt end ligation using large Klenow fragments (NEB) to ligate sticky ends. 2A-puro was replaced with an amplified 2A-blasticidin sequence with NheI and MluI sites
-
Vector typeMammalian Expression, Lentiviral, CRISPR
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCas9
-
Alt nameS. pyogenes CRISPR-Cas9
-
SpeciesSynthetic
-
Insert Size (bp)4224
- Promoter EFS-NS
-
Tag
/ Fusion Protein
- FLAG (N terminal on insert)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer pLLU-F
- 3′ sequencing primer blast-R (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made bylentiCRISPR pXPR_001 (Addgene 49535)
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Lenti‐Cas9‐2A‐Blast was a gift from Jason Moffat (Addgene plasmid # 73310 ; http://n2t.net/addgene:73310 ; RRID:Addgene_73310) -
For your References section:
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities. Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S, Mero P, Dirks P, Sidhu S, Roth FP, Rissland OS, Durocher D, Angers S, Moffat J. Cell. 2015 Dec 3;163(6):1515-26. doi: 10.1016/j.cell.2015.11.015. Epub 2015 Nov 25. 10.1016/j.cell.2015.11.015 PubMed 26627737